SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progression.
Fischietti M, Eckerdt F, Perez RE, Guillen Magaña JN, Mazewski C, Ho S, Gonzalez C, Streich LD, Beauchamp EM, Heimberger AB, et al. Cancer Res Commun. 2022 Sep; 2(9):966-978. Epub 2022 Sep 13.